AOX BIOPHARMA

Serial Number 97284711
689

Registration Progress

Application Filed
Feb 25, 2022
Under Examination
Approved for Publication
Jan 7, 2025
Published for Opposition
Jan 7, 2025
Registered

Trademark Image

AOX BIOPHARMA

Basic Information

Serial Number
97284711
Filing Date
February 25, 2022
Published for Opposition
January 7, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
689
Status Date
Jan 16, 2025
Application
Pending
Classes
042

Rights Holder

AOX BIOPHARMA LLC

16
Address
PO BOX 268
ST. CHARLES, IL 60174

Ownership History

AOX BIOPHARMA LLC

Original Applicant
16
ST. CHARLES, IL

AOX BIOPHARMA LLC

Owner at Publication
16
ST. CHARLES, IL

USPTO Deadlines

All Deadlines Cleared

All 7 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
Feb 22, 2025 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED Loading...
Feb 22, 2025 WOAG I WITHDRAWAL OF ATTORNEY GRANTED Loading...
Jan 16, 2025 ISSR Z WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST Loading...
Jan 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 7, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 16, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 9, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 9, 2024 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Feb 9, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jan 26, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 25, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 25, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 26, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 26, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 26, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 12, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 11, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 11, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 11, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jul 11, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Apr 11, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 11, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Apr 11, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 13, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 13, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 15, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 15, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 2, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 1, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development; Scientific research and development; Scientific research in the field of preparations and substances for the treatment of skin

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMA"